tiprankstipranks
Diaceutics (GB:DXRX)
LSE:DXRX
Holding GB:DXRX?
Track your performance easily

Diaceutics (DXRX) Financial Statements

10 Followers

Diaceutics Financial Overview

Diaceutics's market cap is currently ―. The company's EPS TTM is p-0.033; its P/E ratio is -40.19; Diaceutics is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is p0.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 19.84M£ 20.39M£ 19.68M£ 23.75M£ 25.25M
Total Assets£ 48.26M£ 45.53M£ 45.01M£ 42.49M£ 43.52M
Total Debt£ 1.33M£ 1.41M£ 1.56M£ 124.00K£ 118.00K
Net Debt£ -18.51M£ -18.97M£ -18.11M£ -23.62M£ -25.14M
Total Liabilities£ 5.74M£ 4.58M£ 4.36M£ 2.50M£ 3.28M
Stockholders Equity£ 42.51M£ 40.95M£ 40.65M£ 39.99M£ 40.24M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

Diaceutics Earnings and Revenue History

Diaceutics Debt to Assets

Diaceutics Cash Flow

Diaceutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis